{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T08:46:47.256651+00:00","published_at":"2026-10-17T04:45:14.05764+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:seat_on:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:9:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"seat_on","from_id":"alpha:person:arthur-f-ryan","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Anita J. Ryan","to_label":"Regeneron Pharmaceuticals","valid_from":"2003-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:10:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"seat_on","from_id":"alpha:person:bonnie-l-bassler","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Bonnie L. Bassler","to_label":"Regeneron Pharmaceuticals","valid_from":"2016-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:11:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"seat_on","from_id":"alpha:person:christine-a-poon","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Christine A. Poon","to_label":"Regeneron Pharmaceuticals","valid_from":"2010-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:lead_independent_director_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:11:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"lead_independent_director_of","from_id":"alpha:person:christine-a-poon","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Christine A. Poon","to_label":"Regeneron Pharmaceuticals","valid_from":"2010-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:12:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"seat_on","from_id":"alpha:person:craig-b-thompson","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Craig B. Thompson","to_label":"Regeneron Pharmaceuticals","valid_from":"2022-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:13:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"seat_on","from_id":"alpha:person:david-p-schenkein","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"David P. Schenkein","to_label":"Regeneron Pharmaceuticals","valid_from":"2023-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:14:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"seat_on","from_id":"alpha:person:george-d-yancopoulos","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"George D. Yancopoulos","to_label":"Regeneron Pharmaceuticals","valid_from":"2001-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:14","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:15:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"seat_on","from_id":"alpha:person:george-l-sing","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"George L. Sing","to_label":"Regeneron Pharmaceuticals","valid_from":"1988-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:15","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:16:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"seat_on","from_id":"alpha:person:huda-y-zoghbi","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Huda Y. Zoghbi","to_label":"Regeneron Pharmaceuticals","valid_from":"2016-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:16","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:17:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"seat_on","from_id":"alpha:person:joseph-l-goldstein","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Joseph L. Goldstein","to_label":"Regeneron Pharmaceuticals","valid_from":"1991-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:17","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:18:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"seat_on","from_id":"alpha:person:kathryn-guarini","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Kathryn Guarini","to_label":"Regeneron Pharmaceuticals","valid_from":"2023-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:18","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:19:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"seat_on","from_id":"alpha:person:leonard-s-schleifer","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Leonard S. Schleifer","to_label":"Regeneron Pharmaceuticals","valid_from":"1988-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:19","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:20:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"seat_on","from_id":"alpha:person:michael-s-brown","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Michael S. Brown","to_label":"Regeneron Pharmaceuticals","valid_from":"1991-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:20","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:21:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"seat_on","from_id":"alpha:person:n-anthony-coles","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"N. Anthony Coles","to_label":"Regeneron Pharmaceuticals","valid_from":"2017-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:21","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:28:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"committee_of","from_id":"alpha:committee:regeneron-pharmaceuticals-inc:audit","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Audit","to_label":"Regeneron Pharmaceuticals","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:28","evidence_ids":["alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8"]},{"relationship_id":"alpha:relationship:chairs:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:28:committee:regeneron-pharmaceuticals-inc:audit","relationship_type":"chairs","from_id":"alpha:person:george-l-sing","to_id":"alpha:committee:regeneron-pharmaceuticals-inc:audit","from_label":"George L. Sing","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:28","evidence_ids":["alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8"]},{"relationship_id":"alpha:relationship:member_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:28:committee:regeneron-pharmaceuticals-inc:audit","relationship_type":"member_of","from_id":"alpha:person:arthur-f-ryan","to_id":"alpha:committee:regeneron-pharmaceuticals-inc:audit","from_label":"Anita J. Ryan","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:28","evidence_ids":["alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:15:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"committee_of","from_id":"alpha:committee:regeneron-pharmaceuticals-inc:audit-chair-compensation","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Audit · Chair; Compensation","to_label":"Regeneron Pharmaceuticals","valid_from":"1988-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:15","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:member_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:15:committee:regeneron-pharmaceuticals-inc:audit-chair-compensation","relationship_type":"member_of","from_id":"alpha:person:george-l-sing","to_id":"alpha:committee:regeneron-pharmaceuticals-inc:audit-chair-compensation","from_label":"George L. Sing","to_label":"Audit · Chair; Compensation","valid_from":"1988-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:15","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:9:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"committee_of","from_id":"alpha:committee:regeneron-pharmaceuticals-inc:audit-corporate-governance-and-compliance-chair","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Audit; Corporate Governance and Compliance · Chair","to_label":"Regeneron Pharmaceuticals","valid_from":"2003-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:member_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:9:committee:regeneron-pharmaceuticals-inc:audit-corporate-governance-and-compliance-chair","relationship_type":"member_of","from_id":"alpha:person:arthur-f-ryan","to_id":"alpha:committee:regeneron-pharmaceuticals-inc:audit-corporate-governance-and-compliance-chair","from_label":"Anita J. Ryan","to_label":"Audit; Corporate Governance and Compliance · Chair","valid_from":"2003-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:31:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"committee_of","from_id":"alpha:committee:regeneron-pharmaceuticals-inc:compensation","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Compensation","to_label":"Regeneron Pharmaceuticals","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:31","evidence_ids":["alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8"]},{"relationship_id":"alpha:relationship:chairs:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:31:committee:regeneron-pharmaceuticals-inc:compensation","relationship_type":"chairs","from_id":"alpha:person:christine-a-poon","to_id":"alpha:committee:regeneron-pharmaceuticals-inc:compensation","from_label":"Christine A. Poon","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:31","evidence_ids":["alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8"]},{"relationship_id":"alpha:relationship:member_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:31:committee:regeneron-pharmaceuticals-inc:compensation","relationship_type":"member_of","from_id":"alpha:person:george-l-sing","to_id":"alpha:committee:regeneron-pharmaceuticals-inc:compensation","from_label":"George L. Sing","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:31","evidence_ids":["alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:11:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"committee_of","from_id":"alpha:committee:regeneron-pharmaceuticals-inc:compensation-chair-corporate-governance-and-compliance","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Compensation · Chair; Corporate Governance and Compliance","to_label":"Regeneron Pharmaceuticals","valid_from":"2010-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:member_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:11:committee:regeneron-pharmaceuticals-inc:compensation-chair-corporate-governance-and-compliance","relationship_type":"member_of","from_id":"alpha:person:christine-a-poon","to_id":"alpha:committee:regeneron-pharmaceuticals-inc:compensation-chair-corporate-governance-and-compliance","from_label":"Christine A. Poon","to_label":"Compensation · Chair; Corporate Governance and Compliance","valid_from":"2010-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:34:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"committee_of","from_id":"alpha:committee:regeneron-pharmaceuticals-inc:corporate-governance-and-compliance","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Corporate Governance and Compliance","to_label":"Regeneron Pharmaceuticals","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:34","evidence_ids":["alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8"]},{"relationship_id":"alpha:relationship:chairs:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:34:committee:regeneron-pharmaceuticals-inc:corporate-governance-and-compliance","relationship_type":"chairs","from_id":"alpha:person:arthur-f-ryan","to_id":"alpha:committee:regeneron-pharmaceuticals-inc:corporate-governance-and-compliance","from_label":"Anita J. Ryan","to_label":"Corporate Governance and Compliance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:34","evidence_ids":["alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8"]},{"relationship_id":"alpha:relationship:member_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:34:committee:regeneron-pharmaceuticals-inc:corporate-governance-and-compliance","relationship_type":"member_of","from_id":"alpha:person:christine-a-poon","to_id":"alpha:committee:regeneron-pharmaceuticals-inc:corporate-governance-and-compliance","from_label":"Christine A. Poon","to_label":"Corporate Governance and Compliance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:34","evidence_ids":["alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:12:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"committee_of","from_id":"alpha:committee:regeneron-pharmaceuticals-inc:corporate-governance-and-compliance-digital-technology-technology","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Corporate Governance and Compliance; Digital Technology; Technology","to_label":"Regeneron Pharmaceuticals","valid_from":"2022-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:member_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:12:committee:regeneron-pharmaceuticals-inc:corporate-governance-and-compliance-digital-technology-technology","relationship_type":"member_of","from_id":"alpha:person:craig-b-thompson","to_id":"alpha:committee:regeneron-pharmaceuticals-inc:corporate-governance-and-compliance-digital-technology-technology","from_label":"Craig B. Thompson","to_label":"Corporate Governance and Compliance; Digital Technology; Technology","valid_from":"2022-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:38:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"committee_of","from_id":"alpha:committee:regeneron-pharmaceuticals-inc:digital-technology","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Digital Technology","to_label":"Regeneron Pharmaceuticals","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:38","evidence_ids":["alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8"]},{"relationship_id":"alpha:relationship:member_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:38:committee:regeneron-pharmaceuticals-inc:digital-technology","relationship_type":"member_of","from_id":"alpha:person:craig-b-thompson","to_id":"alpha:committee:regeneron-pharmaceuticals-inc:digital-technology","from_label":"Craig B. Thompson","to_label":"Digital Technology","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:38","evidence_ids":["alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:40:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"committee_of","from_id":"alpha:committee:regeneron-pharmaceuticals-inc:technology","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Technology","to_label":"Regeneron Pharmaceuticals","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:40","evidence_ids":["alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8"]},{"relationship_id":"alpha:relationship:member_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:40:committee:regeneron-pharmaceuticals-inc:technology","relationship_type":"member_of","from_id":"alpha:person:craig-b-thompson","to_id":"alpha:committee:regeneron-pharmaceuticals-inc:technology","from_label":"Craig B. Thompson","to_label":"Technology","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:40","evidence_ids":["alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:26:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"executive_of","from_id":"alpha:person:leonard-s-schleifer","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Leonard S. Schleifer","to_label":"Regeneron Pharmaceuticals","valid_from":"2026-02-04","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:26","evidence_ids":["alpha:projection-evidence:document:d1265880b1e2ef08d82c9a445c87fe66862069e264638236b86548dd48aa0a99"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:22:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"executive_of","from_id":"alpha:person:andrew-j-murphy-ph-d","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Andrew J. Murphy, Ph.D.","to_label":"Regeneron Pharmaceuticals","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:22","evidence_ids":["alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:23:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"executive_of","from_id":"alpha:person:christopher-fenimore","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Christopher Fenimore","to_label":"Regeneron Pharmaceuticals","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:23","evidence_ids":["alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:24:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"executive_of","from_id":"alpha:person:daniel-p-van-plew","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Daniel P. Van Plew","to_label":"Regeneron Pharmaceuticals","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:24","evidence_ids":["alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:25:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"executive_of","from_id":"alpha:person:george-d-yancopoulos-m-d-ph-d-regeneron-pharmaceuticals-inc","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"George D. Yancopoulos, M.D., Ph.D.","to_label":"Regeneron Pharmaceuticals","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:25","evidence_ids":["alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:27:company:bee12477-9858-4107-8779-4e9347bf356a","relationship_type":"executive_of","from_id":"alpha:person:leonard-s-schleifer-m-d-ph-d-regeneron-pharmaceuticals-inc","to_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","from_label":"Leonard S. Schleifer, M.D., Ph.D.","to_label":"Regeneron Pharmaceuticals","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:27","evidence_ids":["alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043"]}]},"claims":[{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:9","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:arthur-f-ryan","object_label":"Anita J. Ryan","object_source_name_forms":[],"value":"Anita J. Ryan: Independent Director, Audit; Corporate Governance and Compliance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:arthur-f-ryan","name":"Anita J. Ryan"},"title":"Independent Director","role_category":"director","committee":"Audit; Corporate Governance and Compliance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2003-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2003-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2003-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:10","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:bonnie-l-bassler","object_label":"Bonnie L. Bassler","object_source_name_forms":[],"value":"Bonnie L. Bassler: Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:bonnie-l-bassler","name":"Bonnie L. Bassler"},"title":"Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:11","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:christine-a-poon","object_label":"Christine A. Poon","object_source_name_forms":[],"value":"Christine A. Poon: Lead Independent Director, Compensation · Chair; Corporate Governance and Compliance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:christine-a-poon","name":"Christine A. Poon"},"title":"Lead Independent Director","role_category":"director","committee":"Compensation · Chair; Corporate Governance and Compliance","is_board_chair":false,"is_independent":true,"start_date":"2010-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2010-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2010-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:12","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:craig-b-thompson","object_label":"Craig B. Thompson","object_source_name_forms":[],"value":"Craig B. Thompson: Director, Corporate Governance and Compliance; Digital Technology; Technology","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:craig-b-thompson","name":"Craig B. Thompson"},"title":"Director","role_category":"director","committee":"Corporate Governance and Compliance; Digital Technology; Technology","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:13","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-p-schenkein","object_label":"David P. Schenkein","object_source_name_forms":[],"value":"David P. Schenkein: Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-p-schenkein","name":"David P. Schenkein"},"title":"Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:14","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:george-d-yancopoulos","object_label":"George D. Yancopoulos","object_source_name_forms":[],"value":"George D. Yancopoulos: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:george-d-yancopoulos","name":"George D. Yancopoulos"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2001-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2001-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2001-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:15","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:george-l-sing","object_label":"George L. Sing","object_source_name_forms":[],"value":"George L. Sing: Independent Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:george-l-sing","name":"George L. Sing"},"title":"Independent Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"1988-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"1988-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"1988-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:16","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:huda-y-zoghbi","object_label":"Huda Y. Zoghbi","object_source_name_forms":[],"value":"Huda Y. Zoghbi: Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:huda-y-zoghbi","name":"Huda Y. Zoghbi"},"title":"Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:17","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:joseph-l-goldstein","object_label":"Joseph L. Goldstein","object_source_name_forms":[],"value":"Joseph L. Goldstein: Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:joseph-l-goldstein","name":"Joseph L. Goldstein"},"title":"Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"1991-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"1991-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"1991-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:18","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kathryn-guarini","object_label":"Kathryn Guarini","object_source_name_forms":[],"value":"Kathryn Guarini: Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kathryn-guarini","name":"Kathryn Guarini"},"title":"Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:19","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:leonard-s-schleifer","object_label":"Leonard S. Schleifer","object_source_name_forms":[],"value":"Leonard S. Schleifer: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:leonard-s-schleifer","name":"Leonard S. Schleifer"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"1988-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"1988-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"1988-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:20","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-s-brown","object_label":"Michael S. Brown","object_source_name_forms":[],"value":"Michael S. Brown: Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-s-brown","name":"Michael S. Brown"},"title":"Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"1991-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"1991-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"1991-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:21","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:n-anthony-coles","object_label":"N. Anthony Coles","object_source_name_forms":[],"value":"N. Anthony Coles: Independent Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:n-anthony-coles","name":"N. Anthony Coles"},"title":"Independent Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:22","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:andrew-j-murphy-ph-d","object_label":"Andrew J. Murphy, Ph.D.","object_source_name_forms":[],"value":"Andrew J. Murphy, Ph.D.: Executive Vice President, Co-Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:andrew-j-murphy-ph-d","name":"Andrew J. Murphy, Ph.D."},"title":"Executive Vice President, Co-Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000340","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-09-14T16:52:57.731588+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:23","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:christopher-fenimore","object_label":"Christopher Fenimore","object_source_name_forms":[],"value":"Christopher Fenimore: Executive Vice President, Finance and Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:christopher-fenimore","name":"Christopher Fenimore"},"title":"Executive Vice President, Finance and Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000340","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-09-14T16:52:57.731588+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:24","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:daniel-p-van-plew","object_label":"Daniel P. Van Plew","object_source_name_forms":[],"value":"Daniel P. Van Plew: Executive Vice President and General Manager, Industrial Operations and Product Supply","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:daniel-p-van-plew","name":"Daniel P. Van Plew"},"title":"Executive Vice President and General Manager, Industrial Operations and Product Supply","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000340","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-09-14T16:52:57.731588+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:25","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:george-d-yancopoulos-m-d-ph-d-regeneron-pharmaceuticals-inc","object_label":"George D. Yancopoulos, M.D., Ph.D.","object_source_name_forms":[],"value":"George D. Yancopoulos, M.D., Ph.D.: Board co-Chair, President and Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:george-d-yancopoulos-m-d-ph-d-regeneron-pharmaceuticals-inc","name":"George D. Yancopoulos, M.D., Ph.D."},"title":"Board co-Chair, President and Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000340","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-09-14T16:52:57.731588+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:26","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:leonard-s-schleifer","object_label":"Leonard S. Schleifer","object_source_name_forms":[],"value":"Leonard S. Schleifer: Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:leonard-s-schleifer","name":"Leonard S. Schleifer"},"title":"Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-04","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-04","valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:d1265880b1e2ef08d82c9a445c87fe66862069e264638236b86548dd48aa0a99","identity_scope":"source_document_reference","source_type":"sec_filing","title":"REGN 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm","source_date":"2026-02-04T00:00:00+00:00","retrieved_at":"2026-07-11T00:40:32.155611+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-04T00:00:00+00:00","effective_from":"2026-02-04","effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:leadership_role:27","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:leonard-s-schleifer-m-d-ph-d-regeneron-pharmaceuticals-inc","object_label":"Leonard S. Schleifer, M.D., Ph.D.","object_source_name_forms":[],"value":"Leonard S. Schleifer, M.D., Ph.D.: Board co-Chair, President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:leonard-s-schleifer-m-d-ph-d-regeneron-pharmaceuticals-inc","name":"Leonard S. Schleifer, M.D., Ph.D."},"title":"Board co-Chair, President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000340","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-09-14T16:52:57.731588+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.95,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:28","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair George L. Sing; Members George L. Sing (Chair); Anita J. Ryan","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"George L. Sing","members":[{"display_name":"George L. Sing","person_slug":"george-l-sing","is_chair":true},{"display_name":"Anita J. Ryan","person_slug":"arthur-f-ryan","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:31","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Christine A. Poon; Members Christine A. Poon (Chair); George L. Sing","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Christine A. Poon","members":[{"display_name":"Christine A. Poon","person_slug":"christine-a-poon","is_chair":true},{"display_name":"George L. Sing","person_slug":"george-l-sing","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:34","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Corporate Governance and Compliance: Chair Anita J. Ryan; Members Anita J. Ryan (Chair); Christine A. Poon; Craig B. Thompson","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Corporate Governance and Compliance","canonical_type":"nominating_governance","chair":"Anita J. Ryan","members":[{"display_name":"Anita J. Ryan","person_slug":"arthur-f-ryan","is_chair":true},{"display_name":"Christine A. Poon","person_slug":"christine-a-poon","is_chair":false},{"display_name":"Craig B. Thompson","person_slug":"craig-b-thompson","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:38","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Digital Technology: Chair not stated; Members Craig B. Thompson","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Digital Technology","canonical_type":"technology","chair":null,"members":[{"display_name":"Craig B. Thompson","person_slug":"craig-b-thompson","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:bee12477-9858-4107-8779-4e9347bf356a:committee_record:40","subject_id":"alpha:company:bee12477-9858-4107-8779-4e9347bf356a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Technology: Chair not stated; Members Craig B. Thompson","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Technology","canonical_type":"technology","chair":null,"members":[{"display_name":"Craig B. Thompson","person_slug":"craig-b-thompson","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:14.05764+00:00","sources":[{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:6e9bd9d2b15eb2753d0fde483cdcf45b0d19938579315e42b24582ad7f75faf3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24","retrieved_at":"2026-04-24T20:10:05.384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:bfaa15f5ba82da1d14fb28148e414ec5206e186b9707d93429af346776541043","identity_scope":"source_document_reference","source_type":"sec_def_14a","title":"SEC DEF 14A 0001308179-26-000340","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-09-14T16:52:57.731588+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:d1265880b1e2ef08d82c9a445c87fe66862069e264638236b86548dd48aa0a99","identity_scope":"source_document_reference","source_type":"sec_filing","title":"REGN 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm","source_date":"2026-02-04T00:00:00+00:00","retrieved_at":"2026-07-11T00:40:32.155611+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:158ef090c3ad2807947a27e846a1bcfe83a16821367e4fc9ca00a2e35137f4b8","identity_scope":"representation_reference","source_type":"sp500-board-director-completeness-remediation-2026-05-15","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.834,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.879,"cross_source_agreement":0.75,"temporal_completeness":0.533},"diagnostics":{"published_claims":43,"factual_claims":43,"claims_with_linked_evidence":43,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":30,"temporal_claims_with_valid_from":16,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:45:14.05764+00:00","observed_at":"2026-10-17T04:45:14.05764+00:00","reviewed_at":"2026-10-17T04:45:14.05764+00:00","verified_at":"2026-10-17T04:45:14.05764+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":43,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/regeneron-pharmaceuticals-inc/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/regeneron-pharmaceuticals-inc?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}